Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Eur J Med Res
Agafina, Alina (Autor:in) / Aguiar, Valeria Cristina (Autor:in) / Rossovskaya, Maria (Autor:in) / Fartoukh, Muriel Sarah (Autor:in) / Hajjar, Ludhmila Abrahao (Autor:in) / Thiéry, Guillaume (Autor:in) / Timsit, Jean-François (Autor:in) / Gordeev, Ivan (Autor:in) / Protsenko, Denis (Autor:in) / Carbone, Javier (Autor:in)
13.08.2024
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Double blind placebo controlled exposure to molds: exposure system and clinical results*
Wiley | 2005
|Elsevier | 2024
|